Genocea Biosciences (GNCA) News Today Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Genocea Biosciences (NASDAQ:GNCA) Earns Sell Rating from Analysts at StockNews.comNovember 18 at 3:27 AM | americanbankingnews.comStockNews.com Initiates Coverage on Genocea Biosciences (NASDAQ:GNCA)November 13, 2024 | americanbankingnews.comGenocea Biosciences Inc GNCAQJanuary 5, 2024 | morningstar.comGNCAQ Genocea Biosciences, Inc.January 27, 2023 | seekingalpha.com3 Health Care Stocks Under $10 to Trade for BreakoutsAugust 31, 2022 | thestreet.comGenocea Biosciences, Inc. (GNCA)August 9, 2022 | uk.finance.yahoo.comGRPN, GNCA and LAB among mid-day moversMay 27, 2022 | seekingalpha.comGenocea Biosciences to shut downMay 25, 2022 | finance.yahoo.comGenocea Closes Shop, Delists From NASDAQMay 24, 2022 | finance.yahoo.comThree weeks after layoffs, Genocea shuts down entirelyMay 24, 2022 | finance.yahoo.comGenocea stock crashes 64% on winding down of operations, Nasdaq delistingMay 24, 2022 | seekingalpha.comGenocea Announces Wind Down of Operations and Delisting From NASDAQMay 24, 2022 | finance.yahoo.comGenocea cuts two-thirds of staff, explores a saleMay 2, 2022 | finance.yahoo.comGenocea stock plunges on cutting workforce by 65% and exploring sale or merger alternatives; Stifel cuts PT to $0.16April 29, 2022 | seekingalpha.comGenocea Initiates Restructuring and Announces Plan to Explore Strategic AlternativesApril 28, 2022 | finance.yahoo.comTrading was temporarily halted for "GNCA" at 04:04 PM with a stated reason of "News pending."April 28, 2022 | marketbeat.comImplied Volatility Surging for Genocea (GNCA) Stock OptionsApril 11, 2022 | finance.yahoo.comGenocea Biosciences Stock Dives After Early Data From GEN-011 Trial In Pretreated Solid Tumor PatientsApril 8, 2022 | uk.investing.comGenocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR 2022April 8, 2022 | finance.yahoo.comGenocea Biosciences to Host Investor WebinarApril 4, 2022 | finance.yahoo.comGenocea to Present at the 32nd Annual Oppenheimer Healthcare ConferenceMarch 14, 2022 | finance.yahoo.comGenocea Biosciences GAAP EPS of -$0.19 misses by $0.01March 10, 2022 | seekingalpha.comGenocea Biosciences: Q4 Earnings SnapshotMarch 10, 2022 | apnews.comGenocea Provides Fourth Quarter 2021 Corporate UpdateMarch 10, 2022 | finance.yahoo.comGenocea Biosciences Q4 2021 Earnings PreviewMarch 9, 2022 | seekingalpha.comGenocea Biosciences Earnings PreviewMarch 9, 2022 | benzinga.comGenocea to Present Clinical and Preclinical Data at AACR Annual MeetingMarch 8, 2022 | finance.yahoo.comGenocea to Host Fourth Quarter 2021 Corporate Update Conference Call & WebcastMarch 3, 2022 | finance.yahoo.comGenocea to Present at the 11th Annual SVB Leerink Global Healthcare ConferenceFebruary 10, 2022 | finance.yahoo.comThe Petri Dish: Janssen inks two local deals, Biogen licenses new drugJanuary 6, 2022 | bizjournals.comGenocea to Present at Upcoming Investor ConferencesJanuary 5, 2022 | finance.yahoo.comGenocea Biosciences Provides Corporate UpdateJanuary 4, 2022 | finance.yahoo.comGenocea Biosciences Inc Shares Close the Day 19.7% Higher - Daily WrapDecember 24, 2021 | nasdaq.comGenocea to Present at the Stifel 2021 Virtual Healthcare ConferenceNovember 10, 2021 | finance.yahoo.comGenocea Provides Third Quarter 2021 Corporate UpdateOctober 28, 2021 | finance.yahoo.comWhat Wall Street expects from Genocea Biosciences's earningsOctober 27, 2021 | markets.businessinsider.comGenocea to Host Third Quarter 2021 Corporate Update Conference Call & WebcastOctober 21, 2021 | finance.yahoo.comGenocea to Present at Upcoming ConferencesSeptember 29, 2021 | finance.yahoo.comGenocea to Present at Upcoming Scientific and Investor ConferencesSeptember 7, 2021 | benzinga.comDo Options Traders Know Something About Genocea (GNCA) Stock We Don't?August 23, 2021 | finance.yahoo.comGenocea Biosciences: Q2 Earnings SnapshotJuly 29, 2021 | sfgate.comGenocea Provides Second Quarter 2021 Corporate UpdateJuly 29, 2021 | finance.yahoo.comGenocea Biosciences earnings preview: what Wall Street is expectingJuly 28, 2021 | markets.businessinsider.comGenocea to Host Second Quarter 2021 Corporate Update Conference Call & WebcastJuly 22, 2021 | finance.yahoo.com Get Genocea Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GNCA and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! GNCA Media Mentions By Week GNCA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNCA News Sentiment▼0.000.47▲Average Medical News Sentiment GNCA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNCA Articles This Week▼10▲GNCA Articles Average Week Get Genocea Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GNCA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMPE News Today STAB News Today EFTR News Today ALVO News Today BTMDW News Today BCTXW News Today CLVR News Today FBIOP News Today GOVXW News Today LVTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNCA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genocea Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genocea Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNCA Stock Alerts